Sponsor
Tongji Hospital
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Tongji Hospital appears in 85 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownSafety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.NCT07526493 · lead sponsor · 2026-04-01
RECRUITINGHuman Umbilical Cord Mesenchymal Stem Cell Injection for Diabetic NephropathyNCT07822152 · lead sponsor · 2026-03-25
RECRUITINGCD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune DiseasesNCT07337785 · lead sponsor · 2025-12-12
RECRUITINGEffects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted Thoracoscopic SurgeryNCT07028593 · lead sponsor · 2025-07-31
RECRUITINGAdjuvant EGFR-TKI Therapy After Surgery for EGFR-Mutant High-Risk Stage IA2-IIB NSCLCNCT07837739 · lead sponsor · 2025-07-02
RECRUITINGEfficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 DiabetesNCT06964620 · lead sponsor · 2025-05-15
RECRUITINGThe Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes MellitusNCT07128186 · lead sponsor · 2025-04-22
RECRUITINGIntraoperative Paravertebral Block and Postoperative ComplicationsNCT07211529 · lead sponsor · 2025-03-25
RECRUITINGSafety of Etomidate-propofol Mixture vs. Propofol for Total Intravenous Anesthesia in Elderly Patients Undergoing Abdominal SurgeryNCT07019246 · lead sponsor · 2025-02-01
RECRUITINGEfficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)NCT06474520 · lead sponsor · 2024-08-08
RECRUITINGBiomarkers in Autoimmune Disease of Nervous SystemNCT06502015 · lead sponsor · 2024-07-31
RECRUITINGAn In-situ Detection for MicroRNANCT06529614 · lead sponsor · 2024-07-20
RECRUITINGAdebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast CancerNCT06149130 · lead sponsor · 2024-01-11
RECRUITINGCardiorespiratory Fitness After Lobectomy Versus Sublobar ResectionNCT07841249 · lead sponsor · 2022-08-01
RECRUITINGEstrogen Receptor (ER) PET/CT Imaging in Breast CancerNCT05541367 · lead sponsor · 2021-12-31
RECRUITINGSafety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemNCT04561557 · lead sponsor · 2020-09-22
RECRUITINGEfficacy of Mazdutide on Fatty PancreasNCT07803705 · lead sponsor · 2026-11-15
NOT_YET_RECRUITINGMazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial CancerNCT07781150 · lead sponsor · 2026-11-01
NOT_YET_RECRUITINGTemporal Interference Stimulation for Motor and Non-motor Symptoms in Parkinson's DiseaseNCT07857824 · lead sponsor · 2026-10-10
NOT_YET_RECRUITINGPhase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisNCT07756268 · lead sponsor · 2026-09-16
NOT_YET_RECRUITINGMRI-Guided Temporal Interference Stimulation for Parkinson's DiseaseNCT07827456 · lead sponsor · 2026-09-15
NOT_YET_RECRUITINGPatient-Specific 3D Model-Assisted Preoperative Consultation for Thoracoscopic Lung ResectionNCT07686549 · lead sponsor · 2026-08-01
NOT_YET_RECRUITINGTongji NADs CohortNCT07333196 · lead sponsor · 2026-03-01
NOT_YET_RECRUITINGEfficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR Rheumatoid ArthritisNCT07452445 · lead sponsor · 2026-03-01
NOT_YET_RECRUITINGEfficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.NCT07288749 · lead sponsor · 2026-01-01
NOT_YET_RECRUITINGTACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With Cirrhotic Portal HypertensionNCT07350070 · lead sponsor · 2025-12-31
NOT_YET_RECRUITINGWearable Devices Assist in the Detection, Screening, and Management of Major Diseases in Middle-aged and Elderly PopulationsNCT06980064 · lead sponsor · 2025-06-01
NOT_YET_RECRUITINGPyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain MetastasesNCT06152822 · lead sponsor · 2023-11-30
UNKNOWNDiagnosis Value of SEMA4C in Breast CancerNCT03662633 · lead sponsor · 2023-09-01
UNKNOWNExercise Prehabilitation for Patients With NSCLC Before SurgeryNCT05608759 · lead sponsor · 2022-11-01
COMPLETEDSEMA4C as a Relapse Biomarker in Breast CancerNCT03663153 · lead sponsor · 2022-09-01
UNKNOWNApplication of Carbon Dioxide for Identifying the Intersegmental Plane in Thoracoscopic SegmentectomyNCT05350137 · lead sponsor · 2022-02-11
COMPLETEDThe Effects of TMZ on Diabetic NephropathyNCT05147194 · lead sponsor · 2022-01-01
UNKNOWNThe Effects of Neuraminidase Inhibitor Oseltamivir in Patients With Chronic Heart FailureNCT05008679 · lead sponsor · 2021-02-25
UNKNOWNEUS-guided PSE in Combination With EUS-guided Treatment of Varices for Patients With Portal HypertensionNCT04692805 · lead sponsor · 2021-01-05
UNKNOWNEffect of Levosimendan on miRNAs Regulation in the Failing HeartsNCT04950569 · lead sponsor · 2020-10-29
UNKNOWNThe Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19NCT04341480 · lead sponsor · 2020-07-01
UNKNOWNA Real-world Study for Patients With Multiple Pulmonary Ground-glass NodulesNCT04192201 · lead sponsor · 2019-12-31
UNKNOWNRadical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate CancerNCT04093375 · lead sponsor · 2019-11-01
NOT_YET_RECRUITINGDocetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLCNCT03799601 · lead sponsor · 2019-03-01
UNKNOWNCystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder InvasionNCT03482089 · lead sponsor · 2018-06-12
UNKNOWNRadiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung CancerNCT04835025 · lead sponsor · 2018-01-01
SUSPENDEDA Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung CancerNCT03427567 · lead sponsor · 2017-12-01
COMPLETEDQuality Control and Evaluation in Standard COPD ManagementNCT03314077 · lead sponsor · 2017-11-01
COMPLETEDMaintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung CancerNCT03595644 · lead sponsor · 2017-02-12
COMPLETEDPGE1 Improves Coronary Microcirculation Dysfunction in Patients With CAD and DiabetesNCT03159559 · lead sponsor · 2017-01-01
UNKNOWNEvaluation of Clinical and Genetic Modifiers of Long-term Survival in Heart FailureNCT03461107 · lead sponsor · 2016-04-18
UNKNOWNAsthma Biomarkers for Predicting Response to TherapyNCT01973751 · lead sponsor · 2013-11-01
UNKNOWNHepatectomy for Early-stage HCC Patients With CSPHNCT05402644 · lead sponsor · 2009-12-01
COMPLETEDNanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung CancerNCT07150663 · collaborator · 2025-08-20
RECRUITINGSafety and Efficacy of IMPT or IMRT for Breast CancerNCT06826885 · collaborator · 2024-12-01
RECRUITINGExploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)NCT05598528 · collaborator · 2021-09-28
RECRUITINGThe Chinese Familial Alzheimer's NetworkNCT03657732 · collaborator · 2005-01-10
RECRUITINGChina Cognition and Aging StudyNCT03653156 · collaborator · 2000-01-01
RECRUITINGDual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo TransferNCT07811895 · collaborator · 2026-09-01
NOT_YET_RECRUITINGStudy on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPDNCT07665359 · collaborator · 2026-07-01
NOT_YET_RECRUITINGResearch on the Characteristics of Chronic Airway Diseases (asthma, COPD)NCT06685315 · collaborator · 2024-12-01
NOT_YET_RECRUITINGTechnetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast CancerNCT07764653 · collaborator · 2024-01-02
COMPLETEDA Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart FailureNCT05824923 · collaborator · 2023-08-14
ACTIVE_NOT_RECRUITINGMulticenter, Prospective Clinical Study of the Serum Raman Spectroscopy Intelligent System for the Diagnosis of Prostate CancerNCT05854940 · collaborator · 2023-06-10
UNKNOWNDrugs studied in this sponsor's trials
15 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Tongji Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
placebo7
propofol3
budesonide1
budesonide / formoterol1
carboplatin1
cyclophosphamide1
docetaxel1
etomidate1
placebo RxCUI 8375 · Lead sponsor in 4 linked trial(s) · 2 currently recruiting
7 trials
propofol RxCUI 8782 · Lead sponsor in 2 linked trial(s) · 2 currently recruiting
3 trials
budesonide RxCUI 19831 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
budesonide / formoterol RxCUI 389132 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
carboplatin RxCUI 40048 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
cyclophosphamide RxCUI 3002 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting
1 trial
docetaxel RxCUI 72962 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
etomidate RxCUI 4177 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
fludarabine RxCUI 24698 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting
1 trial
gefitinib RxCUI 328134 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
idebenone RxCUI 51296 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
levosimendan RxCUI 73107 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
oseltamivir RxCUI 260101 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
placebo Oral Tablet RxCUI 375221 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
trimetazidine RxCUI 10826 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
lead sponsor49
collaborator36
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.